Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform Read more…
LOS ANGELES, Jan. 7, 2022 /PRNewswire/ — B. Riley Principal 150 Merger Corp. (NASDAQ: BRPMU, BRPM, BRPMW) (“BRPM”), announced today that it has filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement Read more…
SHENZHEN, China, Jan. 07, 2022 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (“FangDD” or the “Company”) (Nasdaq: DUO) today announced that the Company had received a notice from the Nasdaq Stock Market LLC (“Nasdaq”), dated Read more…
NEW YORK, Jan. 7, 2022 /PRNewswire/ — CITIC Capital Acquisition Corp. (CCAC) (“CCAC”), a publicly traded special purpose acquisition company, and Quanergy Systems, Inc. (“Quanergy”), a leading provider of OPA-based solid state LiDAR sensors and smart Read more…
Shareholder rights law firm Robbins LLP informs investors it is investigating the officers and directors of Ipsidy Inc. (AUID) for breaches of fiduciary duties and violations of securities laws. Ipsidy claims to operate an Identity Read more…
Daily Pivots: (S1) 1.1279; (P) 1.1305; (R1) 1.1326; More… EUR/USD is still staying in sideway consolidation form 1.1185 and intraday bias remains neutral. On the downside, break of 1.1185 will resume larger decline from 1.2348. Read more…
Markets are generally steady as focus turns to non-farm payroll from US today. For the week so far, Sterling and Dollar are still the strongest ones, as supported by strong rally in benchmark yields and Read more…
NEW YORK, Jan. 6, 2022 /PRNewswire/ — Weild & Co., the largest independent, decentralized, collaborative and privately-owned investment banking platform, is pleased to announce the addition of Dan McNamara as President of the firm. David Read more…
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today Read more…
US non-farm payroll report is the major focus for today. Markets are expecting 400k job growth in December. Unemployment rate is expected to tick down from 4.2% to 4.1%. Wage growth is expected to continue Read more…